[1] Behera, B., R. Kumari, D. Gochhait, et al., Dermoscopic
Appearance of an Annular Subacute Cutaneous Lupus Erythematosus. Dermatol Pract
Concept[J], 2021. 11(2): e2021013.DOI: 10.5826/dpc.1102a13.[2] Brănișteanu, D.E., S.L. Ianoşi, A. Dimitriu, et al.,
Drug-induced Rowell syndrome, a rare and difficult to manage disease: A case report.
Exp Ther Med[J], 2018. 15(1): 785-788.DOI: 10.3892/etm.2017.5557.[3] Chander, R., P. Yadav, A. Singh, et al., Systemic lupus
erythematosus presenting as erythema annulare centrifugum. Lupus[J], 2014.
23(11): 1197-200.DOI: 10.1177/0961203314534302.[4] Cinotti, E., V. Merlo, W. Kempf, et al., Reticular erythematous
mucinosis: histopathological and immunohistochemical features of 25 patients
compared with 25 cases of lupus erythematosus tumidus. J Eur Acad Dermatol
Venereol[J], 2015. 29(4): 689-97.DOI: 10.1111/jdv.12654.[5] Da Silva Sousa, A.C., M. Campos, A. Oliveira, et al., Bullous
lupus erythematosus with an erythema gyratum repens-like pattern. Dermatol
Online J[J], 2019. 25(1).[6] Fiehn, C., Familial Chilblain Lupus - What Can We Learn from
Type I Interferonopathies? Curr Rheumatol Rep[J], 2017. 19(10): 61.DOI:
10.1007/s11926-017-0689-x.[7] Giacomel, J., I. Zalaudek, G. Argenziano, et al., Dermoscopy of
hypertrophic lupus erythematosus and differentiation from squamous cell
carcinoma. J Am Acad Dermatol[J], 2015. 72(1 Suppl): S33-6.DOI:
10.1016/j.jaad.2014.05.055.[8] Herzum, A., G. Gasparini, E. Cozzani, et al., Atypical and Rare
Forms of Cutaneous Lupus Erythematosus: The Importance of the Diagnosis for the
Best Management of Patients. Dermatology[J], 2022. 238(2): 195-204.DOI:
10.1159/000515766.[9] Kalavala, M., V. Shah and S. Blackford, Subacute cutaneous lupus
erythematosus presenting as erythroderma. Clin Exp Dermatol[J], 2007. 32(4):
388-90.DOI: 10.1111/j.1365-2230.2007.02410.x.[10] Rabba, S., Jr., F. Hali, Sr., F. Marnissi, Sr., et al.,
Papulonodular Mucinosis Associated With Subacute Lupus. Cureus[J], 2022. 14(3):
e23412.DOI: 10.7759/cureus.23412.[11] Sait, H., H. Gangadharan, A. Gupta, et al., Monogenic Lupus
with IgA Nephropathy Caused by Spondyloenchondrodysplasia with Immune
Dysregulation. Indian J Pediatr[J], 2021. 88(8): 819-823.DOI:
10.1007/s12098-020-03636-x.[12] Sprow, G., M. Afarideh, J. Dan, et al., Bullous systemic lupus
erythematosus in females. Int J Womens Dermatol[J], 2022. 8(3): e034.DOI:
10.1097/jw9.0000000000000034.[13] Summers, T.A., Jr., M.B. Lehman, R. Barner, et al., Lupus
mastitis: a clinicopathologic review and addition of a case. Adv Anat Pathol[J],
2009. 16(1): 56-61.DOI: 10.1097/PAP.0b013e3181915ff7.[14] Valandro, L.D.S., M. Beleli, L. Fogagnolo, et al., P53 and
Granzyme B may have a role in progression to malignancy in hypertrophic discoid
lupus erythematosus. JAAD Int[J], 2022. 8: 111-113.DOI:
10.1016/j.jdin.2022.06.008.[15] Voizard, B., L. Lalonde, L.M. Sanchez, et al., Lupus mastitis
as a first manifestation of systemic disease: About two cases with a review of
the literature. Eur J Radiol[J], 2017. 92: 124-131.DOI: 10.1016/j.ejrad.2017.04.023.[16] Yu, J., H. Brandling-Bennett, D.O. Co, et al., Toxic Epidermal
Necrolysis-Like Cutaneous Lupus in Pediatric Patients: A Case Series and
Review. Pediatrics[J], 2016. 137(6).DOI: 10.1542/peds.2015-4497.[17] Zhou, M.Y. and C. Tan, Comedonic discoid lupus erythematous.
Scand J Rheumatol[J], 2019. 48(4): 331-332.DOI: 10.1080/03009742.2019.1571627.[18] Niki, M., Y.
Matsudate, K. Murao, et al., A case of linear cutaneous lupus erythematosus as
an initial manifestation of systemic lupus erythematosus. Int J Dermatol[J],
2021. 60(2): e72-e74.DOI:
10.1111/ijd.15080.(本文仅作为科普与学术交流,增进了解,引起重视,有相关临床症状者,建议及时就医!!!)